{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:19:40Z","timestamp":1761920380594,"version":"build-2065373602"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.msard.2017.12.009","type":"journal-article","created":{"date-parts":[[2017,12,18]],"date-time":"2017-12-18T02:42:23Z","timestamp":1513564943000},"page":"6-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Hepatic microabscesses during CMV reactivation in a multiple sclerosis patient after alemtuzumab treatment"],"prefix":"10.1016","volume":"20","author":[{"given":"Stefania","family":"Barone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Scannapieco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Torti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrica","family":"Filippelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Pisani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfredo","family":"Granata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"Console","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulio","family":"Demonte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiziana","family":"Tallarico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serena","family":"Polidoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aldo","family":"Quattrone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Valentino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.msard.2017.12.009_bib1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2165\/00002018-200730040-00001","article-title":"Drug-induced liver injury","volume":"30","author":"Abboud","year":"2007","journal-title":"Drug Saf."},{"issue":"6","key":"10.1016\/j.msard.2017.12.009_bib2","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1177\/1352458517693440","article-title":"Opportunistic infections after alemtuzumab: new cases of norcardial infection and cytomegalovirus syndrome","volume":"23","author":"Brownlee","year":"2017","journal-title":"Mult. Scler."},{"issue":"6","key":"10.1016\/j.msard.2017.12.009_bib3","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1177\/1352458516688350","article-title":"Active CMV infection in two patients with multiple sclerosis treated with alemtuzumab","volume":"23","author":"Clerico","year":"2017","journal-title":"Mult. Scler."},{"issue":"4","key":"10.1016\/j.msard.2017.12.009_bib4","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/cncr.11551","article-title":"Phase II study of alemtuzumab in chronic lymphoproliferative disorders","volume":"98","author":"Ferrajoli","year":"2003","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.msard.2017.12.009_bib5","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/1352458514549398","article-title":"Alemtuzumab: a new therapy for active relapsing-remitting multiple sclerosis","volume":"21","author":"Hartung","year":"2015","journal-title":"Mult. Scler."},{"issue":"3","key":"10.1016\/j.msard.2017.12.009_bib6","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/clinids\/22.3.537","article-title":"Cytomegalovirus infection following liver transplantation: review of the literature","volume":"22","author":"Kanj","year":"1996","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.msard.2017.12.009_bib7","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/hep.510260125","article-title":"Mini-microabscess syndrome in liver transplant recipients","volume":"26","author":"MacDonald","year":"1997","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.msard.2017.12.009_bib8","doi-asserted-by":"crossref","first-page":"632","DOI":"10.4254\/wjh.v6.i9.632","article-title":"Liver involvement in systemic infection","volume":"6","author":"Minemura","year":"2014","journal-title":"World J. Hepatol."},{"issue":"2","key":"10.1016\/j.msard.2017.12.009_bib9","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3816\/CLM.2006.n.049","article-title":"Updated guidelines on the management of cytomegalovirus reactivation in patients with chronic lymphocytic leukemia treated with alemtuzumab","volume":"7","author":"O'Brien","year":"2006","journal-title":"Clin. Lymphoma Myeloma"},{"issue":"1","key":"10.1016\/j.msard.2017.12.009_bib10","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00277-016-2831-7","article-title":"Cytomegalovirus infection in patients with haematological diseases and after autologous stem cell transplantation as consolidation: a single-centre study","volume":"96","author":"Piukovics","year":"2017","journal-title":"Ann. Hematol."},{"issue":"18","key":"10.1016\/j.msard.2017.12.009_bib11","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1200\/JCO.2002.06.119","article-title":"Alemtuzumab in previously treated chronic lymphocytic leukemia patients who also had received fludarabine","volume":"20","author":"Rai","year":"2002","journal-title":"J. Clin. Oncol."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034817303516?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034817303516?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:43:23Z","timestamp":1761900203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034817303516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":11,"alternative-id":["S2211034817303516"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2017.12.009","relation":{},"ISSN":["2211-0348"],"issn-type":[{"type":"print","value":"2211-0348"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatic microabscesses during CMV reactivation in a multiple sclerosis patient after alemtuzumab treatment","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2017.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}